Developer docs
API playgroundTry for free, no card

Search company profiles

Swing Therapeutics

Full company profile

uuid000046w

Namestring
Swing Therapeutics
Legal namestring
Swing Therapeutics, Inc.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Swing Therapeutics, Inc. is a San Francisco-based digital therapeutics company founded in 2019 that develops evidence-based, software-delivered treatments for chronic conditions, with a primary focus on fibromyalgia. Its flagship product, Stanza, is an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a 12-week, 15-20-minute daily smartphone program available on iOS and Android. The underlying technology is a content-driven behavioral therapy engine backed by an exclusive license from the University of Manitoba, with 17 software releases and 7 clinical trials supporting iterative product refinement; the Phase 3 PROSPER-FM trial (275 participants) published in The Lancet represents the largest randomized controlled trial ever conducted on a fibromyalgia device treatment.

The company operates a dual business model. Stanza is distributed as a prescription-only digital therapeutic through three channels: the iOS App Store and Google Play Store (where it can be downloaded with a valid prescription), clinical partner practices (UPMC in Pennsylvania, Southwest Medical in Nevada), and Swing Care — Swing's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management, lifestyle coaching, and Stanza. Swing Care currently operates in eight states (Illinois, Tennessee, Texas, Pennsylvania, Michigan, Missouri, Nevada, Ohio). Reimbursement is enabled through payer coverage decisions, with Highmark Health providing commercial coverage for members across Pennsylvania, West Virginia, Delaware, and New York. Revenue is generated through insurance reimbursement for prescription fills and through professional services fees from Swing Care, though specific pricing and revenue figures are not publicly disclosed.

Short descriptiontext

Swing Therapeutics develops Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy via smartphone for adults with fibromyalgia, complemented by its Swing Care virtual specialty clinic operating in eight U.S. states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics, prescription digital therapy, fibromyalgia treatment, behavioral health software, chronic pain management
Industry3 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code3 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Prepackaged Software7372
Product category
Digital Therapeutics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Prescription Digital Therapeutic Sales
TypeSubscription Recurring
Description

Stanza is prescribed by healthcare providers and reimbursed through insurance. The company has secured coverage decisions from payers like Highmark Health for their commercial members.

swingtherapeutics.com
2Swing Care Virtual Clinic Services
TypeProfessional Services
Description

Swing Care, a specialty virtual clinic for fibromyalgia treatment, offers comprehensive care including medication management and non-pharmacological therapies, with Stanza as a treatment option. Services are available in Illinois, Tennessee, Texas, and Pennsylvania.

swingtherapeutics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Prescription digital therapeutic covered by insurance
ModelSubscriptionBilling cadenceNot disclosed
Notes

Insurance reimbursement through payers like Highmark Health; specific pricing not publicly disclosed

swingtherapeutics.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 of 2 records shown
1Stanza
Description

FDA-cleared digital behavioral therapy for treatment of fibromyalgia symptoms in adult patients. Delivers Acceptance and Commitment Therapy (ACT) through a smartphone application.

swingtherapeutics.com
+1 more record
Core offering1 text field

Swing Therapeutics develops and sells Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for adult patients with fibromyalgia. The 12-week, 15-minute-per-day self-guided program includes lessons, mindfulness exercises, journaling, and symptom tracking, and is complemented by Swing Care, the company's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management and Stanza as a care option.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 11 values shown
  • 73% of patients saw improvement in well-being (vs Control)
+10 more records
Product overview1 text field

Swing Therapeutics is a digital therapeutics company offering a portfolio of products focused on chronic pain conditions, primarily fibromyalgia. The core product is Stanza, an FDA-cleared digital behavioral therapy delivering Acceptance and Commitment Therapy (ACT) via smartphone app. This is complemented by Swing Care, a virtual specialty clinic that provides comprehensive, multimodal fibromyalgia treatment incorporating Stanza as one care option alongside medication management and lifestyle support. The products work together to provide both standalone digital therapy access and integrated clinical care delivery.

Product and service2 records
1Stanza
CategoryPrescription Digital Therapeutic
Description

Stanza is an FDA-cleared prescription digital behavioral therapy that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for the treatment of fibromyalgia symptoms in adult patients. The 12-week self-guided program includes 15-minute daily lessons, mindfulness activities, journaling, symptom tracking, and reminders, available on iOS and Android devices.

2Swing Care
CategoryVirtual Specialty Clinic / Telehealth Services
Description

Swing Care is a virtual specialty clinic offering personalized, comprehensive fibromyalgia treatment that combines non-opioid pharmacological approaches with non-drug treatments including Stanza, medication management, lifestyle coaching, sleep management, and peer support. Services are available across multiple U.S. states including Illinois, Tennessee, Texas, Pennsylvania, Michigan, Missouri, Nevada, and Ohio.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Exclusive license of clinically validated online therapy program for digital delivery. The foundational program showed improvement in function and symptoms for people living with fibromyalgia through clinical trial.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Positive coverage decision for Stanza enabling commercial members in Pennsylvania, West Virginia, Delaware, and New York to access the treatment by prescription with insurance reimbursement.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Clinical partner in Pennsylvania offering Stanza as a treatment option for fibromyalgia patients.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Clinical partner in Nevada offering Stanza as a treatment option for fibromyalgia patients.

Strategic tierMinorTypeGTM or Marketing Partner
Description

NYU Stern accelerator program that graduated Swing Therapeutics in its 2025-2026 cohort. EFL has facilitated $3.20 billion raised by 243 graduates.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Pear Therapeutics
TypeDirect peer
Description

Former category-leading prescription digital therapeutics company (reSET, reSET-O, Somryst) that pioneered FDA-authorized PDTs and filed for bankruptcy in 2023. Most directly comparable to Swing in regulatory pathway, prescription distribution model, and therapeutic modality; the appointment of Pear's former CEO to Swing's board underscores the strategic similarity.

2Better Therapeutics
TypeDirect peer
Description

Prescription digital therapeutic company developing BT-001 for type 2 diabetes and other cardiometabolic conditions via behavioral intervention. Comparable as a venture-backed PDT company pursuing FDA authorization and payer reimbursement for chronic-condition DTx.

TypeDirect peer
Description

FDA-authorized prescription digital therapeutic company (EndeavorRx for ADHD, EndeavorOTC) later acquired by Virtual Therapeutics. Closely comparable in PDT regulatory model, payer engagement, and consumer-facing digital therapy positioning.

TypeDirect peer
Description

Prescription digital therapeutics company with FDA-authorized products (e.g., CT-132 for migraine) and a pipeline spanning chronic conditions. Directly comparable as a venture-backed PDT peer pursuing FDA pathway and payer coverage.

TypeDirect peer
Description

Digital therapeutics company (Sleepio for insomnia, Daylight for anxiety) combining CBT-based digital therapy with payer and employer distribution. Comparable in CBT/behavioral digital therapy modality, chronic-condition focus, and payer-reimbursement strategy.

TypeDirect peer
Description

Digital therapeutics company developing FDA-authorized prescription DTx (previously Parallel, now Mahana IBS for irritable bowel syndrome). Comparable as a chronic-condition PDT pursuing regulatory and payer pathway in a specialty indication.

TypeBroad incumbent
Description

Large-scale digital MSK and chronic pain platform combining virtual PT, coaching, and wearable sensors; serves employers and payers. Comparable in chronic-pain digital care delivery, payer engagement, and value-based care positioning, though Hinge is significantly larger and more diversified.

TypeBroad incumbent
Description

Established virtual chronic care platform (diabetes prevention, hypertension, MSK) with payer and employer distribution at scale. Comparable in digital chronic-condition care, payer reimbursement model, and emphasis on durable clinical outcomes.

TypeBroad incumbent
Description

Digital mental health and behavioral therapy company (Headspace, Ginger) offering CBT/mindfulness-based programs via app with employer and payer distribution. Comparable in behavioral therapy modality and payer/employer GTM, though broader scope than a single-condition DTx.

TypeEmerging player
Description

Digital chronic pain management program using CBT and pain neuroscience education via app, with consumer and B2B distribution. Comparable as a chronic-pain digital therapy with behavioral (CBT) approach, though typically sold direct-to-consumer rather than as prescription DTx.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Swing Therapeutics

Digital Therapeuticsswingtherapeutics.com

Swing Therapeutics develops Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy via smartphone for adults with fibromyalgia, complemented by its Swing Care virtual specialty clinic operating in eight U.S. states.

What Swing Therapeutics does

Swing Therapeutics, Inc. is a San Francisco-based digital therapeutics company founded in 2019 that develops evidence-based, software-delivered treatments for chronic conditions, with a primary focus on fibromyalgia. Its flagship product, Stanza, is an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a 12-week, 15-20-minute daily smartphone program available on iOS and Android. The underlying technology is a content-driven behavioral therapy engine backed by an exclusive license from the University of Manitoba, with 17 software releases and 7 clinical trials supporting iterative product refinement; the Phase 3 PROSPER-FM trial (275 participants) published in The Lancet represents the largest randomized controlled trial ever conducted on a fibromyalgia device treatment.

The company operates a dual business model. Stanza is distributed as a prescription-only digital therapeutic through three channels: the iOS App Store and Google Play Store (where it can be downloaded with a valid prescription), clinical partner practices (UPMC in Pennsylvania, Southwest Medical in Nevada), and Swing Care — Swing's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management, lifestyle coaching, and Stanza. Swing Care currently operates in eight states (Illinois, Tennessee, Texas, Pennsylvania, Michigan, Missouri, Nevada, Ohio). Reimbursement is enabled through payer coverage decisions, with Highmark Health providing commercial coverage for members across Pennsylvania, West Virginia, Delaware, and New York. Revenue is generated through insurance reimbursement for prescription fills and through professional services fees from Swing Care, though specific pricing and revenue figures are not publicly disclosed.

Swing Therapeutics firmographics

Firmographics
Name
Swing Therapeutics
Legal name
Swing Therapeutics, Inc.
Website
https://swingtherapeutics.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Swing Therapeutics develops Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy via smartphone for adults with fibromyalgia, complemented by its Swing Care virtual specialty clinic operating in eight U.S. states.
Ownership category
akta.pro rank

Swing Therapeutics industry classification

Industry
Product category
Digital Therapeutics
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Digital therapeutics
  • Prescription digital therapy
  • Fibromyalgia treatment
  • Behavioral health software
  • Chronic pain management

Where Swing Therapeutics is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Swing Therapeutics business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Prescription Digital Therapeutic Sales: Stanza is prescribed by healthcare providers and reimbursed through insurance. The company has secured coverage decisions from payers like Highmark Health for their commercial members.
  2. Swing Care Virtual Clinic Services: Swing Care, a specialty virtual clinic for fibromyalgia treatment, offers comprehensive care including medication management and non-pharmacological therapies, with Stanza as a treatment option. Services are available in Illinois, Tennessee, Texas, and Pennsylvania.

Pricing tiers

ModelBillingPrice
SubscriptionNot disclosedPrescription digital therapeutic covered by insurance

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Swing Therapeutics product offering

Product offering

Core offering

Swing Therapeutics develops and sells Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for adult patients with fibromyalgia. The 12-week, 15-minute-per-day self-guided program includes lessons, mindfulness exercises, journaling, and symptom tracking, and is complemented by Swing Care, the company's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management and Stanza as a care option.

Product overview

Swing Therapeutics is a digital therapeutics company offering a portfolio of products focused on chronic pain conditions, primarily fibromyalgia. The core product is Stanza, an FDA-cleared digital behavioral therapy delivering Acceptance and Commitment Therapy (ACT) via smartphone app. This is complemented by Swing Care, a virtual specialty clinic that provides comprehensive, multimodal fibromyalgia treatment incorporating Stanza as one care option alongside medication management and lifestyle support. The products work together to provide both standalone digital therapy access and integrated clinical care delivery.

Differentiator

Problem solved

Functional benefit

Brands

  • Stanza: FDA-cleared digital behavioral therapy for treatment of fibromyalgia symptoms in adult patients. Delivers Acceptance and Commitment Therapy (ACT) through a smartphone application.
  • Swing Care

Products and services

  • Stanza Stanza is an FDA-cleared prescription digital behavioral therapy that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for the treatment of fibromyalgia symptoms in adult patients. The 12-week self-guided program includes 15-minute daily lessons, mindfulness activities, journaling, symptom tracking, and reminders, available on iOS and Android devices.
  • Swing Care Swing Care is a virtual specialty clinic offering personalized, comprehensive fibromyalgia treatment that combines non-opioid pharmacological approaches with non-drug treatments including Stanza, medication management, lifestyle coaching, sleep management, and peer support. Services are available across multiple U.S. states including Illinois, Tennessee, Texas, Pennsylvania, Michigan, Missouri, Nevada, and Ohio.

Quantifiable outcome

  • 73% of patients saw improvement in well-being (vs Control)
  • +10 more outcomes

Companies that use Swing Therapeutics

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles3 records

Swing Therapeutics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Swing Therapeutics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • University of ManitobacoreStrategic or Co-development PartnerExclusive license of clinically validated online therapy program for digital delivery. The foundational program showed improvement in function and symptoms for people living with fibromyalgia through clinical trial.
  • Highmark HealthcoreChannel Partner/ Reseller/ DistributorPositive coverage decision for Stanza enabling commercial members in Pennsylvania, West Virginia, Delaware, and New York to access the treatment by prescription with insurance reimbursement.
  • UPMCminorChannel Partner/ Reseller/ DistributorClinical partner in Pennsylvania offering Stanza as a treatment option for fibromyalgia patients.
  • Southwest MedicalminorChannel Partner/ Reseller/ DistributorClinical partner in Nevada offering Stanza as a treatment option for fibromyalgia patients.
  • Endless Frontier Labs (EFL)minorGTM or Marketing PartnerNYU Stern accelerator program that graduated Swing Therapeutics in its 2025-2026 cohort. EFL has facilitated $3.20 billion raised by 243 graduates.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Swing Therapeutics competitors and assessment

Company assessment

Direct peers

  • Pear Therapeutics: Former category-leading prescription digital therapeutics company (reSET, reSET-O, Somryst) that pioneered FDA-authorized PDTs and filed for bankruptcy in 2023. Most directly comparable to Swing in regulatory pathway, prescription distribution model, and therapeutic modality; the appointment of Pear's former CEO to Swing's board underscores the strategic similarity.
  • Better Therapeutics: Prescription digital therapeutic company developing BT-001 for type 2 diabetes and other cardiometabolic conditions via behavioral intervention. Comparable as a venture-backed PDT company pursuing FDA authorization and payer reimbursement for chronic-condition DTx.
  • Akili Interactive: FDA-authorized prescription digital therapeutic company (EndeavorRx for ADHD, EndeavorOTC) later acquired by Virtual Therapeutics. Closely comparable in PDT regulatory model, payer engagement, and consumer-facing digital therapy positioning.
  • Click Therapeutics: Prescription digital therapeutics company with FDA-authorized products (e.g., CT-132 for migraine) and a pipeline spanning chronic conditions. Directly comparable as a venture-backed PDT peer pursuing FDA pathway and payer coverage.
  • Big Health: Digital therapeutics company (Sleepio for insomnia, Daylight for anxiety) combining CBT-based digital therapy with payer and employer distribution. Comparable in CBT/behavioral digital therapy modality, chronic-condition focus, and payer-reimbursement strategy.
  • Mahana Therapeutics: Digital therapeutics company developing FDA-authorized prescription DTx (previously Parallel, now Mahana IBS for irritable bowel syndrome). Comparable as a chronic-condition PDT pursuing regulatory and payer pathway in a specialty indication.

Broad incumbents

  • Hinge Health: Large-scale digital MSK and chronic pain platform combining virtual PT, coaching, and wearable sensors; serves employers and payers. Comparable in chronic-pain digital care delivery, payer engagement, and value-based care positioning, though Hinge is significantly larger and more diversified.
  • Omada Health: Established virtual chronic care platform (diabetes prevention, hypertension, MSK) with payer and employer distribution at scale. Comparable in digital chronic-condition care, payer reimbursement model, and emphasis on durable clinical outcomes.
  • Headspace Health: Digital mental health and behavioral therapy company (Headspace, Ginger) offering CBT/mindfulness-based programs via app with employer and payer distribution. Comparable in behavioral therapy modality and payer/employer GTM, though broader scope than a single-condition DTx.

Emerging players

  • Curable Health: Digital chronic pain management program using CBT and pain neuroscience education via app, with consumer and B2B distribution. Comparable as a chronic-pain digital therapy with behavioral (CBT) approach, though typically sold direct-to-consumer rather than as prescription DTx.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Swing Therapeutics social profiles

Digital presence

Swing Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Swing Therapeutics leadership team

Management profile

Number of profiles

Profiles7 records

Swing Therapeutics funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Swing Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Swing Therapeutics

What does Swing Therapeutics do?

Swing Therapeutics develops and sells Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for adult patients with fibromyalgia. The 12-week, 15-minute-per-day self-guided program includes lessons, mindfulness exercises, journaling, and symptom tracking, and is complemented by Swing Care, the company's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management and Stanza as a care option.

Is Swing Therapeutics a public or private company?

Swing Therapeutics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Swing Therapeutics founded?

Swing Therapeutics was founded in 2019. It employs 11 to 50 people.

Where is Swing Therapeutics based?

Swing Therapeutics is headquartered in San Francisco, United States, in the North America region.

How does Swing Therapeutics make money?

Two revenue lines are on record. Prescription Digital Therapeutic Sales are the primary driver. The others are swing Care Virtual Clinic Services.

Who are Swing Therapeutics's main competitors?

Direct peers on record are Pear Therapeutics, Better Therapeutics, Akili Interactive, Click Therapeutics, Big Health and Mahana Therapeutics. Broad incumbents are Hinge Health, Omada Health and Headspace Health. Curable Health is listed as an emerging player.

Does Swing Therapeutics have an API?

No public API is recorded for Swing Therapeutics.

What industry is Swing Therapeutics in?

Swing Therapeutics's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 621112 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HLTHXRHealth Acquires Swing Therapeutics to Expand Extended Reality Platform for Chronic Pain CareXRHealth acquired Swing Therapeutics to expand its extended reality platform for chronic pain care, combining digital therapeutics and virtual clinical care. The deal includes Stanza, an FDA De Novo-authorized digital behavioral therapy for fibromyalgia, and Swing Care, a virtual clinic. The combined platform operates licensed virtual clinics across 22 U.S. states.FoleyFoley Advises Swing Therapeutics on Sale to XRHealthFoley & Lardner LLP served as legal counsel advising Swing Therapeutics, a leading developer of digital therapies, on its sale to XRHealth, a therapeutic technology platform. The acquisition brings Swing Therapeutics’ FDA De Novo-authorized Stanza prescription digital behavioral therapeutic program for fibromyalgia and chronic pain into XRHealth’s platform, which delivers care through VR glasses, smartphones, and wearables and is reimbursed through Medicare, VA programs, and commercial insurance.BostonGlobe.comSwing Therapeutics acquired by medical VR platform XRHealthSwing Therapeutics, developer of an FDA-cleared digital treatment for fibromyalgia, has been acquired by medical virtual reality company XRHealth. The acquisition marks XRHealth's sixth purchase in two years as the company pivots to position itself as a comprehensive provider of digital treatments for various diseases. Financial terms of the deal were not disclosed.HIT ConsultantXRHealth Acquires Swing Therapeutics to Create Largest Extended Reality Chronic Pain PlatformXRHealth has completed the acquisition of digital therapeutics company Swing Therapeutics, creating the largest multi-device extended reality digital health platform for chronic conditions. The deal incorporates Swing's FDA De Novo-authorized Stanza program for fibromyalgia treatment, backed by a Phase 3 randomized controlled trial published in The Lancet, alongside Swing Care, a multidisciplinary virtual specialty clinic. The combined platform operates across 22 U.S. states, deploys via VR glasses, smartphones, and wearables, and is reimbursed through Medicare Part B, VA programs, and commercial insurance, with reported clinical outcomes showing 88% of patients reporting statistically significant improvement.PrwebXRHealth Acquires Swing Therapeutics, Expanding Its Platform to Mobile Digital TherapeuticsXRHealth announced the acquisition of Swing Therapeutics, a developer of FDA-authorized digital therapeutics and the virtual care platform Swing Care, creating what it claims is the largest extended reality digital health platform for chronic conditions. The acquisition expands XRHealth's reach from augmented and virtual reality glasses into smartphone apps, smartwatches, and IoT devices while adding Swing's FDA De Novo-authorized Stanza program, the first digital behavioral therapy for fibromyalgia, to its chronic pain and behavioral health capabilities. The combined platform will serve patients across physical, cognitive, and behavioral health, with over 88% of Swing Care patients reporting improvement in overall wellbeing at the one-year mark.STATSwing Therapeutics acquired by medical VR platform XR Health | STATSwing Therapeutics, a developer of FDA-cleared digital treatment for fibromyalgia, was acquired by VR health platform XR Health. The deal marks XR Health's expansion into digital treatments for various diseases, with the company's platform offering multiple FDA-registered VR apps.STATSwing Therapeutics acquired by medical VR platform XR HealthXR Health acquired Swing Therapeutics, a developer of an FDA-cleared digital treatment for fibromyalgia. The deal is XR Health's sixth acquisition in two years, with terms undisclosed. The company aims to become a go-to source for digital treatments, having delivered a million user sessions in 2025.Streamline FeedInside XR Health's Strategic Acquisition of Digital Fibromyalgia Pioneer Swing TherapeuticsXR Health acquired Swing Therapeutics, a developer of an FDA-cleared digital treatment for fibromyalgia, merging its cognitive behavioral therapy protocols with XR Health's VR platform. The deal aims to expand XR Health's chronic pain market presence and integrate biometric tracking into therapy sessions. Financial terms were not disclosed.STATWhy clinical trials for digital therapeutics are getting more rigorousSwing Therapeutics conducted a year-long pivotal trial for its fibromyalgia app Stanza, using a sham app as a control. The sham, which provided only educational materials, is a standard practice for FDA submissions, as seen in Otsuka and Curio Digital Therapeutics' cleared treatments.Business Wire BlogSwing Therapeutics Announces Positive Results from Pivotal Phase 3 Trial of Stanza, a Digital Therapy for Fibromyalgia SymptomsSwing Therapeutics announced positive results from its Phase 3 PROSPER-FM trial of Stanza, a digital therapy for fibromyalgia. At week 12, 70.6% of participants improved on the PGIC scale versus 22.2% in the control arm, with no treatment-related adverse events. The FDA granted De Novo marketing authorization in May 2023.